Pure Global

Emanutec insulin precursor C-Shengxi reagent - Taiwan Registration 926672b36bfe8bc5133c68633856e9ed

Access comprehensive regulatory information for Emanutec insulin precursor C-Shengxi reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 926672b36bfe8bc5133c68633856e9ed and manufactured by IMMUNOTECH S.R.O.. The authorized representative in Taiwan is MEGA BONA INTERNATIONAL CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
926672b36bfe8bc5133c68633856e9ed
Registration Details
Taiwan FDA Registration: 926672b36bfe8bc5133c68633856e9ed
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Emanutec insulin precursor C-Shengxi reagent
TW: ไผŠๆ›ผ็ด็‰นๅ…‹่ƒฐๅณถ็ด ๅ‰่ณชC-่ƒœๅ‘”่ฉฆๅŠ‘
Risk Class 2

Registration Details

926672b36bfe8bc5133c68633856e9ed

DHAS5603585407

Company Information

Czechia

Product Details

This product is used by extracorporeal radiation immunoassay to determine the insulin precursor C-Shengxin in human serum and plasma.

A Clinical chemistry and clinical toxicology

A.1135 ่ƒฐๅณถ็ด ๅ‰่ณชC-่‚ฝ้กž่ฉฆ้ฉ—็ณป็ตฑ

Consent must be attached to the import (with the consent of the Atomic Energy Commission must be obtained for each import); QMS/QSD;; input

Dates and Status

Sep 21, 2022

Sep 21, 2027